Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute of Oncology Ljubljana

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Institute of Oncology Ljubljana is Slovenia's leading comprehensive cancer center and a nationally recognized institution for oncology research, integrating patient care, education, and scientific innovation. The institute conducts a broad spectrum of basic, translational, clinical, and epidemiological research focused on cancer biology, diagnostics, prevention, treatment, immunology, and survivorship. It actively participates in investigator-initiated and international multicenter clinical trials, enabling patients to access novel therapies while contributing to advancements in cancer care. Through its Department of Experimental Oncology, national Cancer Registry, and collaborations with European research networks and academic institutions, the institute promotes precision oncology and evidence-based clinical practice. Its strong emphasis on translating laboratory discoveries into clinical applications and its extensive publication output establish it as a leading hub for…

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
116Total Trials
Source: Trial-derived.
29Recruiting Trials
Source: Trial-derived.
55Active Trials
Source: Trial-derived.
54Completed Trials
Source: Trial-derived.
147Unique Conditions
Source: Trial-derived.
79Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (19)Source: Trial-derived. Cancer (6)Source: Trial-derived. Colon Cancer (5)Source: Trial-derived. Colorectal Cancer (4)Source: Trial-derived. Early Breast Cancer (4)Source: Trial-derived. Melanoma (4)Source: Trial-derived. Metastatic Melanoma (4)Source: Trial-derived. Malignant Melanoma (3)

Sponsors

Source: Trial-derived. Institute of Oncology Ljubljana (74)Source: Trial-derived. Hoffmann-La Roche (15)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (10)Source: Trial-derived. Breast International Group (4)Source: Trial-derived. ETOP IBCSG Partners Foundation (4)Source: Trial-derived. University of Ljubljana (4)Source: Trial-derived. Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (3)Source: Trial-derived. University Medical Centre Ljubljana (3)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Sentinel lymph node biopsy
Source: AI-inferred. Tumour response imaging